资讯

The price of the lifesaving Covid-19 antiviral medication Paxlovid will more than double as the United States transitions out of the emergency phase of the pandemic, drugmaker Pfizer said Wednesday.
On May 16, Pfizer (PFE 0.38%) announced that it was going to take out $31 billion in fresh debt to pay for its purchase of Seagen , an oncology drug developer.
Inside the labs of Pfizer 05:28. A major Pfizer pharmaceutical plant in North Carolina that makes critical supplies for U.S. hospitals has restarted production about 10 weeks after it was heavily ...
Pfizer has struck a deal with Chinese drugmaker CSPC Pharmaceutical Group Ltd. to launch a local brand of Covid-19 antiviral Paxlovid, the latest in a string of partnerships the US giant has ...